A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

NCT06741644 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

660

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: CS2009
DRUG: CS2009
DRUG: Pemetrexed
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Etoposide
DRUG: Nab-paclitaxel
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Docetaxel
DRUG: Leucovorin
DRUG: 5-FU
DRUG: Cisplatin

Sponsor

CStone Pharmaceuticals